Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Revenue

Denali Therapeutics had revenue of $3.60M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $3.60M.

• Revenue (ttm): $3.60M
• Revenue Growth: n/a
• P/S Ratio: 1,013.46
• Revenue / Employee: $7,108
• Employees: 507
• Market Cap: 3.65B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	330.53M	222.07M	204.74%
Dec 31, 2022	108.46M	59.80M	122.90%
Dec 31, 2021	48.66M	-287.00M	-85.50%

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error